Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

382 trials

Showing 20 of 382 results

Large-scale testing (Phase 3)Ended earlyNCT00676143
What this trial is testing

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 1,100
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00099710
What this trial is testing

Curcumin in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
John Douglas French Foundation 33
Testing effectiveness (Phase 2)Study completedNCT00454870
What this trial is testing

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Memory Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT01018875
What this trial is testing

Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 242
Testing effectiveness (Phase 2)UnknownNCT00606164
What this trial is testing

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Blanchette Rockefeller Neurosciences Insitute 9
Testing effectiveness (Phase 2)Study completedNCT00945672
What this trial is testing

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 36
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT03867253
What this trial is testing

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Oryzon Genomics S.A. 24
Not applicableStudy completedNCT02256306
What this trial is testing

The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study

Who this might be right for
Mild-To-Moderate Alzheimer's DiseaseAlzheimer's Disease
Stanford University 18
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)Study completedNCT00880412
What this trial is testing

Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Exonhit 197
Not applicableStudy completedNCT05454540
What this trial is testing

Repetitive TMS of the Posterior DMN in AD

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 60
Large-scale testing (Phase 3)Study completedNCT00104013
What this trial is testing

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,455
Early research (Phase 1)Study completedNCT00988598
What this trial is testing

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Testing effectiveness (Phase 2)Looking for participantsNCT07367815
What this trial is testing

Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 9
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Testing effectiveness (Phase 2)Ended earlyNCT05602727
What this trial is testing

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 99
Testing effectiveness (Phase 2)UnknownNCT01120002
What this trial is testing

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Osaka City University 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation